Gornitzky & Co. represented BiomX in the deal.
BiomX raised $15 million in a transaction under which a number of investors invested through placement agents (Cantor and Chardan).
BiomX, a Delaware company that is traded in the New York Stock Exchange and in the Tel Aviv Stock Exchange, is developing treatments that use bacteria-attacking viruses to treat a variety of illnesses.
The Gornitzky team was led by partner Shy Barnov (Picture), Associates Rebecca Genis and Yarden Wulkan Rozenman.
Law Firms: Gornitzky & Co.;